Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$76.4 - $96.33 $17,266 - $21,770
-226 Reduced 0.87%
25,647 $2.42 Million
Q4 2023

Feb 13, 2024

BUY
$59.53 - $85.11 $3,988 - $5,702
67 Added 0.26%
25,873 $2.06 Million
Q3 2023

Nov 13, 2023

BUY
$69.23 - $79.09 $38,768 - $44,290
560 Added 2.22%
25,806 $1.94 Million
Q2 2023

Aug 04, 2023

BUY
$45.44 - $71.21 $6,588 - $10,325
145 Added 0.58%
25,246 $1.8 Million
Q1 2023

May 12, 2023

BUY
$43.88 - $52.48 $4,256 - $5,090
97 Added 0.39%
25,101 $1.26 Million
Q4 2022

Feb 10, 2023

SELL
$40.82 - $57.75 $7,837 - $11,088
-192 Reduced 0.76%
25,004 $1.09 Million
Q3 2022

Nov 14, 2022

BUY
$46.84 - $58.49 $13,630 - $17,020
291 Added 1.17%
25,196 $1.34 Million
Q2 2022

Aug 12, 2022

SELL
$34.86 - $63.77 $44,795 - $81,944
-1,285 Reduced 4.91%
24,905 $1.13 Million
Q1 2022

May 13, 2022

SELL
$44.33 - $57.82 $70,972 - $92,569
-1,601 Reduced 5.76%
26,190 $1.51 Million
Q4 2021

Feb 11, 2022

SELL
$40.27 - $56.99 $21,947 - $31,059
-545 Reduced 1.92%
27,791 $1.24 Million
Q3 2021

Nov 12, 2021

SELL
$47.43 - $84.23 $45,912 - $81,534
-968 Reduced 3.3%
28,336 $1.37 Million
Q2 2021

Aug 13, 2021

BUY
$73.06 - $97.7 $44,785 - $59,890
613 Added 2.14%
29,304 $2.49 Million
Q1 2021

May 07, 2021

SELL
$70.43 - $97.42 $19,368 - $26,790
-275 Reduced 0.95%
28,691 $2.41 Million
Q4 2020

Feb 12, 2021

SELL
$48.9 - $75.26 $33,887 - $52,155
-693 Reduced 2.34%
28,966 $2.18 Million
Q3 2020

Nov 04, 2020

SELL
$37.23 - $50.97 $223 - $305
-6 Reduced 0.02%
29,659 $1.47 Million
Q2 2020

Aug 12, 2020

BUY
$28.78 - $46.83 $83,375 - $135,666
2,897 Added 10.82%
29,665 $1.14 Million
Q1 2020

May 04, 2020

BUY
$25.53 - $70.14 $61,425 - $168,756
2,406 Added 9.88%
26,768 $826,000
Q4 2019

Feb 05, 2020

BUY
$54.18 - $65.64 $86,092 - $104,301
1,589 Added 6.98%
24,362 $1.33 Million
Q3 2019

Nov 08, 2019

BUY
$58.58 - $83.91 $6,385 - $9,146
109 Added 0.48%
22,773 $1.42 Million
Q2 2019

Aug 13, 2019

BUY
$63.59 - $78.71 $59,393 - $73,515
934 Added 4.3%
22,664 $1.71 Million
Q1 2019

May 06, 2019

SELL
$50.75 - $80.54 $35,677 - $56,619
-703 Reduced 3.13%
21,730 $1.7 Million
Q4 2018

Feb 13, 2019

BUY
$52.18 - $67.93 $27,655 - $36,002
530 Added 2.42%
22,433 $1.26 Million
Q3 2018

Nov 09, 2018

BUY
$38.13 - $68.37 $15,099 - $27,074
396 Added 1.84%
21,903 $1.42 Million
Q2 2018

Aug 08, 2018

BUY
$27.62 - $44.51 $88,301 - $142,298
3,197 Added 17.46%
21,507 $874,000
Q1 2018

May 07, 2018

SELL
$26.05 - $34.5 $25,685 - $34,017
-986 Reduced 5.11%
18,310 $564,000
Q4 2017

Feb 09, 2018

BUY
$24.5 - $36.01 $2,229 - $3,276
91 Added 0.47%
19,296 $495,000
Q3 2017

Nov 09, 2017

BUY
$31.26 - $42.03 $600,348 - $807,186
19,205
19,205 $634,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.2B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.